Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1670822

O=C(O)C(F)(F)F.O=C(O)CCOCCCNC(=O)c1ccc(O)c(C2(c3ccccc3)CCNCC2)c1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.42
ITGA2B P08514 6/20 0.42
ITGA2 P17301 1/20 0.39
TACR1 P25103 1/20 0.38
PDK2 Q15119 2/20 0.37
HPGD P15428 1/20 0.36
MAPT P10636 3/20 0.35
MLYCD O95822 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
GAA P10253 1/20 0.35
NAMPT P43490 2/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1670826 0.96 ITGB3 (0.41) ITGB3ITGA2BITGA2TACR1PDK2
SCHEMBL1670823 0.89 ITGB3 (0.36) ITGB3ITGA2BITGA2TACR1PDK2
SCHEMBL1670831 0.85 SMN1; SMN2 (0.36) ITGB3ITGA2BITGA2TACR1PDK2
SCHEMBL1668840 0.83 NAMPT (0.42) HPGDMAPTCA1CA2NAMPT
SCHEMBL1670835 0.78 OPRM1 (0.43) MAPTCA2NAMPTHDAC1TP53
SCHEMBL12800418 0.76 OPRM1 (0.40) ITGB3ITGA2BTACR1
SCHEMBL12801195 0.74 KDM4E (0.42) TACR1NAMPTHDAC1
Trifluoroacetic Acid SCHEMBL1668669 0.73 APP (0.35) TACR1PDK2
Trifluoroacetic Acid SCHEMBL1668616 0.71 FFAR4 (0.43) TACR1
SCHEMBL1669606 0.71 CA12 (0.47) PDK2HPGDMAPTCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048409-A1 CYCLIC AMINE DERIVATIVES HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY ASTRAZENECA AB (SE) 2011-04-28 WO disclosed